Shanshan Li

Shanshan Li is a microbiologist with extensive experience in biomedical research, currently serving as a Microbiologist 3 in serology at the Centers for Disease Control and Prevention since June 2024, focusing on immune response studies related to poxvirus vaccination. Prior roles include Scientist 2 at Apertor Pharmaceuticals, where development of novel molecular glues for oncology applications was conducted, and a Postdoctoral Researcher at the University of California, San Francisco, specializing in genetically encoding unnatural amino acids and developing covalent protein drugs for SARS-CoV-2 neutralization. Earlier experience as a Research Assistant at Georgia State University involved cancer cell surface engineering to enhance immune responses. Shanshan Li holds a PhD in Biochemistry and Molecular Biology from Georgia State University and a Bachelor's Degree in Pharmaceutical Sciences from Shandong University.